Literature DB >> 31296363

CD14: Biology and role in the pathogenesis of disease.

Zhenghao Wu1, Zhenxiong Zhang2, Zehua Lei3, Ping Lei4.   

Abstract

Human monocyte differentiation antigen CD14 is a pattern recognition receptor (PRR) that enhances innate immune responses. CD14 was first identified as a marker of monocytes to signal intracellular responses upon bacterial encounters. Given the absence of an intracellular tail, CD14 was doubted to have the signaling capacities. Later CD14 was confirmed as the TLR co-receptor for the detection of pathogen-associated molecular patterns. However, CD14 has been revealed as a multi-talented receptor. In last decade, CD14 was identified to activate NFAT to regulate the life cycle of myeloid cells in a TLR4-independent manner and to transport inflammatory lipids to induce phagocyte hyperactivation. And its influences on multiple related diseases have been further considered. In this review, we summarize advancements in the basic biology of the CD14 including its structure, binding ligands, signaling pathways, and its roles in the pathogenesis of inflammation, atherosclerosis, tumor and metabolic diseases. We also discuss the therapeutic potential of targeting the CD14 in related diseases.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD14; Innate immunity; Pattern recognition receptor; Toll like receptor

Mesh:

Substances:

Year:  2019        PMID: 31296363     DOI: 10.1016/j.cytogfr.2019.06.003

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  47 in total

Review 1.  Recent Advances in Good Manufacturing Practice-Grade Generation of Dendritic Cells.

Authors:  Sarah Cunningham; Holger Hackstein
Journal:  Transfus Med Hemother       Date:  2020-10-28       Impact factor: 3.747

2.  Pharmacological validation of targets regulating CD14 during macrophage differentiation.

Authors:  Gisela Jimenez-Duran; Rosario Luque-Martin; Meghana Patel; Emma Koppe; Sharon Bernard; Catriona Sharp; Natalie Buchan; Ceara Rea; Menno P J de Winther; Nil Turan; Davina Angell; Christine A Wells; Rick Cousins; Palwinder K Mander; Seth L Masters
Journal:  EBioMedicine       Date:  2020-10-07       Impact factor: 8.143

3.  Olanzapine Induces Inflammation and Immune Response via Activating ER Stress in the Rat Prefrontal Cortex.

Authors:  Wen-Ting Li; Xu-Feng Huang; Chao Deng; Bao-Hua Zhang; Kun Qian; Meng He; Tao-Lei Sun
Journal:  Curr Med Sci       Date:  2021-08-17

Review 4.  New insights into macrophage subsets in atherosclerosis.

Authors:  Yurong Wang; Qiong Wang; Danyan Xu
Journal:  J Mol Med (Berl)       Date:  2022-08-05       Impact factor: 5.606

5.  Proteomic and Metabolomic Signatures Associated With the Immune Response in Healthy Individuals Immunized With an Inactivated SARS-CoV-2 Vaccine.

Authors:  Yi Wang; Xiaoxia Wang; Laurence Don Wai Luu; Shaojin Chen; Fu Jin; Shufang Wang; Xiaolan Huang; Licheng Wang; Xiaocui Zhou; Xi Chen; Xiaodai Cui; Jieqiong Li; Jun Tai; Xiong Zhu
Journal:  Front Immunol       Date:  2022-05-24       Impact factor: 8.786

6.  A Tumor Progression Related 7-Gene Signature Indicates Prognosis and Tumor Immune Characteristics of Gastric Cancer.

Authors:  Fen Liu; Zongcheng Yang; Lixin Zheng; Wei Shao; Xiujie Cui; Yue Wang; Jihui Jia; Yue Fu
Journal:  Front Oncol       Date:  2021-06-14       Impact factor: 6.244

7.  Olaparib attenuates sepsis-induced acute multiple organ injury via ERK-mediated CD14 expression.

Authors:  Zhixia Chen; Yihui Chen; Xianwei Jin; Ying Liu; Zhenzhen Shao; Quan Li
Journal:  Exp Biol Med (Maywood)       Date:  2021-05-29

8.  Uncomplicated oocyte donation pregnancies display an elevated CD163-positive type 2 macrophage load in the decidua, which is associated with fetal-maternal HLA mismatches.

Authors:  Xuezi Tian; Kaveri T S Aiyer; Johanna M Kapsenberg; Dave L Roelen; Marie-Louise van der Hoorn; Michael Eikmans
Journal:  Am J Reprod Immunol       Date:  2021-12-04       Impact factor: 3.777

Review 9.  Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus.

Authors:  Farzaneh Darbeheshti; Mojdeh Mahdiannasser; Bruce D Uhal; Shuji Ogino; Sudhir Gupta; Nima Rezaei
Journal:  Rev Med Virol       Date:  2021-03-16       Impact factor: 11.043

10.  Folate Receptor β (FRβ) Expression in Tissue-Resident and Tumor-Associated Macrophages Associates with and Depends on the Expression of PU.1.

Authors:  Rafael Samaniego; Ángeles Domínguez-Soto; Manohar Ratnam; Takami Matsuyama; Paloma Sánchez-Mateos; Ángel L Corbí; Amaya Puig-Kröger
Journal:  Cells       Date:  2020-06-10       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.